STERLING, Va.—Euclid Systems Corporation, a global leader in advanced orthokeratology and proactive myopia management, announced two additions to its leadership team as well as the expansion of its manufacturing facility here. The changes come at a time when Euclid’s next-generation of Ortho-K lens, Euclid MAX, is helping to combat the battle against the myopia epidemic, which is expected to affect approximately five billion people worldwide by 2050. “With the launch of our game-changing Euclid Max Ortho-K lens this year, we have entered a very exciting time at Euclid,"  said Euclid Systems CEO, Joseph Boorady.

"But our steadfast commitment to innovation is not taking a break. We’ve just expanded our manufacturing space and employee resources for the second time in three years and continue to grow our leadership team for future expansion. We’re pleased to welcome Greg Endicott and Mark Mercier, who bring decades of experience, innovation, and results in fast-paced health care environments. Their knowledge and leadership, as well as the brick-and-mortar expansion of our facilities, help fortify Euclid’s growth as a cutting-edge world leader in myopia management technologies.”

Space at the Euclid facility here has now been expanded over 40 percent. Additions include larger manufacturing space, quality assurance labs, offices, and engineering and R&D space.

As chief information officer (CIO), Endicott will lead Euclid’s strategic technology program and drive business initiatives in collaboration with global business leaders, including exploration of emerging technologies and new strategies. Previously,  Endicott had a leadership role at Baxter Bioscience and was inaugural CIO of two scientific research companies. 

Mercier is the new senior director of operations. He is a transformation specialist with decades of experience in contact lens manufacturing at Bausch+Lomb. Mercier will drive efficient methodologies throughout Euclid’s manufacturing and fulfillment.

Euclid is a global leader in advanced orthokeratology and proactive myopia management. Euclid is the exclusive manufacturer of the Euclid Emerald and Euclid MAX Ortho-K contact lenses for overnight wear to reshape the cornea and wake up to clear vision.
Today, Euclid is proven on over two million eyes around the world. With headquarters in Virginia and offices in Shanghai and Beijing, China, Euclid is helping to lead the efforts in proactive myopia management across the globe. Manufactured in the U.S., Euclid orthokeratology lenses have received FDA approval in the U.S., CE mark for Europe, as well as regulatory approvals from numerous countries around the world.